Bangkok Dusit Medical Stock Revenue
BDULFDelisted Stock | USD 0.73 0.00 0.00% |
Bangkok Dusit Medical fundamentals help investors to digest information that contributes to Bangkok Dusit's financial success or failures. It also enables traders to predict the movement of Bangkok Pink Sheet. The fundamental analysis module provides a way to measure Bangkok Dusit's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bangkok Dusit pink sheet.
Bangkok |
Bangkok Dusit Medical Company Revenue Analysis
Bangkok Dusit's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Bangkok Dusit Revenue | 74.45 B |
Most of Bangkok Dusit's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bangkok Dusit Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Bangkok Dusit Medical reported 74.45 B of revenue. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The revenue for all United States stocks is significantly lower than that of the firm.
Bangkok Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bangkok Dusit's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bangkok Dusit could also be used in its relative valuation, which is a method of valuing Bangkok Dusit by comparing valuation metrics of similar companies.Bangkok Dusit is currently under evaluation in revenue category among its peers.
Bangkok Fundamentals
Return On Equity | 0.15 | |||
Return On Asset | 0.0739 | |||
Profit Margin | 0.13 % | |||
Operating Margin | 0.17 % | |||
Current Valuation | 13.03 B | |||
Shares Owned By Institutions | 8.46 % | |||
Price To Earning | 50.79 X | |||
Price To Book | 4.91 X | |||
Price To Sales | 0.14 X | |||
Revenue | 74.45 B | |||
Gross Profit | 24.99 B | |||
EBITDA | 17.64 B | |||
Net Income | 7.94 B | |||
Cash And Equivalents | 16.66 B | |||
Cash Per Share | 1.05 X | |||
Total Debt | 12.5 B | |||
Debt To Equity | 0.21 % | |||
Current Ratio | 1.33 X | |||
Book Value Per Share | 5.41 X | |||
Cash Flow From Operations | 14.56 B | |||
Earnings Per Share | 0.02 X | |||
Number Of Employees | 45 | |||
Beta | 0.43 | |||
Market Capitalization | 13.53 B | |||
Total Asset | 128.45 B | |||
Retained Earnings | 28.38 B | |||
Working Capital | (3.49 B) | |||
Current Asset | 12.76 B | |||
Current Liabilities | 16.25 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.02 % | |||
Net Asset | 128.45 B | |||
Last Dividend Paid | 0.5 |
About Bangkok Dusit Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bangkok Dusit Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bangkok Dusit using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bangkok Dusit Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Bangkok Pink Sheet
If you are still planning to invest in Bangkok Dusit Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bangkok Dusit's history and understand the potential risks before investing.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |